A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

Liver Insufficiency Clinical Trial

Official title:
An Open-Label, Single Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK0431

Status Completed

Clinical Trial Summary

A study to compare the plasma concentrations of MK0431 at different times in patients with hepatic insufficiency vs healthy control subjects.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00696826
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 1
Start date	April 2004
Completion date	May 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00929032` - Liver Transplantation and Reticuloendothelial Clearance Capacity	N/A
Completed	`NCT03515980` - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function	Phase 1
Not yet recruiting	`NCT01828372` - Quantification of Drugs and Their Degradation Products	N/A
Completed	`NCT02120547` - Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment	Phase 1
Completed	`NCT03667157` - Liver Function After Intravenous Methylprednisolone Administration	Phase 4
Completed	`NCT01922323` - Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors	N/A
Recruiting	`NCT01335568` - Hepatocyte Matrix Implant Study Indonesia	Phase 1